Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory Czuczman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Psychopharmacology|November 12, 2020
No differences in delay discounting between smokers with and without HIVCory Czuczman, Morgan Thompson, E Paul Wileyto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Psychopharmacology|November 12, 2020
No differences in delay discounting between smokers with and without HIVCory Czuczman, Morgan Thompson, E Paul Wileyto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 1